March 13, 2026

InMode Ltd. (INMD) Stock Analysis: 31.66% Potential Upside in the Healthcare Sector

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector, particularly within the medical devices industry, presents an intriguing investment opportunity for those with an..

RxSight, Inc. (RXST) Stock Analysis: Unveiling the 31.62% Potential Upside for Investors

RxSight, Inc. (NASDAQ: RXST), a commercial-stage medical technology firm, is garnering attention in the healthcare sector for its innovative approach to cataract surgery. The company specializes..

CorMedix Inc. (CRMD) Stock Analysis: A 127.68% Potential Upside with DefenCath at the Forefront

CorMedix Inc. (CRMD), a promising player in the biotechnology sector, is drawing significant attention from investors seeking robust growth opportunities. With its market capitalization standing at..

Evolus, Inc. (EOLS) Stock Analysis: Exploring a Potential 198% Upside in the Aesthetic Market

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company headquartered in Newport Beach, California, operates in the dynamic healthcare sector, specifically within the drug manufacturers specializing in..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Assessing 23.75% Potential Upside in a Dynamic Biotech Sector

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is a noteworthy player in the biotechnology industry, a sector that continues to captivate investors with its potential for groundbreaking..

Sionna Therapeutics, Inc. (SION) Stock Analysis: A Biotech Contender with a 33.89% Potential Upside

Sionna Therapeutics, Inc. (NASDAQ: SION) has emerged as a compelling player in the healthcare sector, specifically within the biotechnology industry. With a current market capitalization of..

Nuvation Bio Inc. (NUVB) Investor Outlook: 164% Potential Upside and Robust Revenue Growth

Nuvation Bio Inc. (NASDAQ: NUVB) stands out in the biotechnology sector with a remarkable potential upside of 164.43%, making it an intriguing prospect for investors looking..

Vir Biotechnology, Inc. (VIR) Investor Outlook: Analyzing a 119% Potential Upside

Vir Biotechnology, Inc. (NASDAQ: VIR), a clinical-stage biopharmaceutical company, is garnering significant attention from investors due to a remarkable potential upside of 119.17%. With its focus..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Exploring a Potential 52% Upside as Analysts Show Strong Support

Cogent Biosciences, Inc. (NASDAQ: COGT) is making waves in the biotech sector with its promising portfolio of precision therapies targeting genetically defined diseases. Based in Waltham,..

Ardelyx, Inc. (ARDX) Stock Analysis: Potential Upside of 184% with Strong Buy Ratings

Ardelyx, Inc. (NASDAQ: ARDX) has recently captured the attention of investors in the biotechnology sector, boasting a compelling narrative underpinned by a promising product pipeline and..

Syndax Pharmaceuticals, Inc. (SNDX) Stock Analysis: 63% Potential Upside Amid Robust Revenue Growth

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a key player in the biotechnology sector, is poised for significant investor attention as it navigates the competitive landscape of cancer..

Investor Outlook: AMN Healthcare Services Inc (AMN) Targets a 14.62% Upside Amid Sector Growth

AMN Healthcare Services Inc (AMN), a prominent player in the Medical Care Facilities industry, is capturing investor interest with its robust service offerings and a promising..

Embecta Corp. (EMBC) Stock Analysis: Exploring an 89% Potential Upside

Embecta Corp. (NYSE: EMBC), a key player in the medical instruments and supplies industry, is currently catching investor attention with its significant potential upside of 89.18%...

Immunome, Inc. (IMNM) Stock Report: Exploring a 69% Upside in Biotech Innovation

Immunome, Inc. (NASDAQ: IMNM), a prominent player in the biotechnology sector, is capturing significant investor attention with a remarkable potential upside of 69.31%. With a current..

Rocket Pharmaceuticals, Inc. (RCKT) Investor Outlook: Exploring a 66.76% Potential Upside

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) stands at the forefront of the biotechnology industry, emphasizing the development of genetic therapies for rare and devastating diseases. Despite its..

CeriBell, Inc. (CBLL) Stock Analysis: A Promising 51.73% Upside in the Medical Devices Sector

Investors eyeing opportunities in the healthcare sector may want to turn their attention to CeriBell, Inc. (CBLL), a company that stands out for its innovative approach..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Exploring an Impressive 182% Potential Upside

Niagen Bioscience, Inc. (NASDAQ: NAGE) is drawing significant attention from investors, thanks to a remarkable potential upside of 182.16%. Situated in the dynamic biotechnology sector of..

Weave Communications, Inc. (WEAV) Stock Analysis: Exploring an 84% Upside Potential

Weave Communications, Inc. (NASDAQ: WEAV), a prominent player in the health information services industry, is drawing attention with its innovative AI-powered patient communications platform. As the..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: Promising Upside Potential with 44.94% Growth Forecast

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a burgeoning player in the biotechnology sector, has captured the attention of investors with its promising portfolio of therapeutics targeting inflammatory..

Geron Corporation (GERN): Investor Outlook Reveals 112.50% Potential Upside in Biotech Sector

Geron Corporation (NASDAQ: GERN), a noteworthy player in the biotechnology sector, offers intriguing potential for individual investors seeking exposure to the healthcare industry. With a market..

Search

Funds

March 13, 2026

Search

Funds

March 13, 2026

FTSE 100

Funds